These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 55682)

  • 1. Letter: Activities of tobramycin and amikacin against gentamicin-resistant gram-negative bacilli.
    Houang ET; McKay-Ferguson E
    Lancet; 1976 Feb; 1(7956):423-4. PubMed ID: 55682
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
    Moellering RC; Wennersten C; Kunz LJ; Poitras JW
    Am J Med; 1977 Jun; 62(6):873-81. PubMed ID: 868901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M
    Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA; Farrell W; Maskell J; Williams JD
    Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
    Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
    Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies on activities of gentamicin, sisomicin, tobramycin and amikacin (BB-K8) against Pseudomonas sp.
    Dzierzanowska D
    Arch Immunol Ther Exp (Warsz); 1977; 25(6):749-56. PubMed ID: 612299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae.
    Tselentis J; Legakis NJ; Nicolas KJ; Melissinos K; Papavassiliou J
    Chemotherapy; 1980; 26(6):409-17. PubMed ID: 7408554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the AutoMicrobic system for susceptibility testing of aminoglycosides and gram-negative bacilli.
    Hindler JA; Bruckner DA
    J Clin Microbiol; 1987 Mar; 25(3):546-50. PubMed ID: 3571458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of neomycin, kanamycin, tobramycin and amikacin resistance mechanisms in gentamicin-resistant isolates of Enterobacteriaceae.
    Adwan K; Abu-Hasan N; Al-Asmar H
    J Med Microbiol; 1998 Nov; 47(11):1019-21. PubMed ID: 9822302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin].
    Kazmierczak A; Gailliard MC; Pothier P; Siebor E; Portier H
    Nouv Presse Med; 1979 Oct; 8(42):3399-402. PubMed ID: 537884
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H
    J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
    Maes P
    J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of nonfermentative gram-negative bacilli to tobramycin.
    Uwaydah M; Taqi-Eddin AR
    J Infect Dis; 1976 Aug; 134 Suppl():S28-32. PubMed ID: 823278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and mechanisms of aminoglycoside resistance. A ten-year study.
    Phillips I; King A; Shannon K
    Am J Med; 1986 Jun; 80(6B):48-55. PubMed ID: 3728534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.